METHYLDOPA AND HYDROCHLOROTHIAZIDE Drug Patent Profile

✉ Email this page to a colleague

Methyldopa And Hydrochlorothiazide is a drug marketed by Chartwell Rx, Dava Pharms Inc, Ivax Sub Teva Pharms, Parke Davis, Purepac Pharm, Rising, Sandoz, Strides Pharma, Teva, and Watson Labs. and is included in forty-three NDAs.

The generic ingredient in METHYLDOPA AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; methyldopa. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; methyldopa profile page.

US Patents:	0
Applicants:	10
NDAs:	43
Raw Ingredient (Bulk) Api Vendors:	2
DailyMed Link:	METHYLDOPA AND HYDROCHLOROTHIAZIDE at DailyMed

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	METHYLDOPA AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; methyldopa	TABLET;ORAL	071922-001	Aug 29, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	METHYLDOPA AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; methyldopa	TABLET;ORAL	071822-001	Apr 8, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	METHYLDOPA AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; methyldopa	TABLET;ORAL	070614-001	Feb 2, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	METHYLDOPA AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; methyldopa	TABLET;ORAL	070365-001	Mar 19, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	METHYLDOPA AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; methyldopa	TABLET;ORAL	071819-001	Apr 8, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration